PARNATE

LOE Approaching

tranylcypromine sulfate

NDAORALTABLETPriority Review
Approved
Feb 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO).

Indications (3)

major depressive disorder (MDD) in adult patientsdrug interactionsthe need for dietary restrictions (,
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers